Search research articles
Contact Us
Filters
Showing results (81-90 of 101) with videos related to
Page
of 11
Sort By:
Blood Cancer Journal
|
November 17, 2018
Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma
Praful Ravi, Shaji K Kumar, Lindsey Roeker, et al.
European Urology
|
May 22, 2024
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials
Praful Ravi, Wanling Xie, Marc Buyse, et al.
European Urology Oncology
|
November 15, 2024
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer
Praful Ravi, Caiwei Zhong, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2024
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials
Lucia Kwak, Praful Ravi, John G Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2026
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2
Emre Yekedüz, Weiwei Bian, Stephanie E Siegmund, et al.
The Prostate
|
March 19, 2025
Outcome of Subsequent Therapies After <sup>177</sup>Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience
Meryam Losee, Michael Kavanaugh, Mofei Liu, et al.
JAMA Oncology
|
November 23, 2022
Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis
Irbaz Bin Riaz, Mahnoor Islam, Waleed Ikram, et al.
Clinical Genitourinary Cancer
|
July 20, 2024
Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
William Paul Skelton, Jack Masur, Jonathan Thomas, et al.
European Urology
|
December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate
Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
European Urology
|
October 22, 2022
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 101) with videos related to
Sort By:
Page
of 11
Blood Cancer Journal
|
November 17, 2018
Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma
Praful Ravi, Shaji K Kumar, Lindsey Roeker, et al.
European Urology
|
May 22, 2024
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials
Praful Ravi, Wanling Xie, Marc Buyse, et al.
European Urology Oncology
|
November 15, 2024
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer
Praful Ravi, Caiwei Zhong, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2024
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials
Lucia Kwak, Praful Ravi, John G Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2026
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2
Emre Yekedüz, Weiwei Bian, Stephanie E Siegmund, et al.
The Prostate
|
March 19, 2025
Outcome of Subsequent Therapies After <sup>177</sup>Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience
Meryam Losee, Michael Kavanaugh, Mofei Liu, et al.
JAMA Oncology
|
November 23, 2022
Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis
Irbaz Bin Riaz, Mahnoor Islam, Waleed Ikram, et al.
Clinical Genitourinary Cancer
|
July 20, 2024
Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
William Paul Skelton, Jack Masur, Jonathan Thomas, et al.
European Urology
|
December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate
Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
European Urology
|
October 22, 2022
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al.
Page
of 11